In vivo targeting of DC-SIGN-positive antigen-presenting cells in a nonhuman primate model

Journal of Immunotherapy

Volumn 30, Issue 7, 2007, Pages 705-714

  Pereira, Cândida F ^a,e   Torensma, Ruurd ^a   Hebeda, Konnie ^b   Kretz Rommel, Anke ^c   Faas, Susan J ^d   Figdor, Carl G ^a   Adema, Gosse J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Alexion Antibody Technologies Inc   (United States)

^d ALEXION PHARMACEUTICALS   (United States)

^e BURNET INSTITUTE   (Australia)

Author keywords

Anti DC SIGN antibody; Antigen presenting cells; Cynomolgus macaque; Liver; Lymph nodes

Indexed keywords

CD209 ANTIGEN; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AZN D1; OXAZOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL STRUCTURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DENDRITIC CELL; DRUG PROTEIN BINDING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KUPFFER CELL; LIVER SINUSOID; LYMPH NODE; LYMPHOID TISSUE; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SEQUENCE HOMOLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL ADHESION MOLECULES; DENDRITIC CELLS; KUPFFER CELLS; LECTINS, C-TYPE; LYMPH NODES; LYMPHOID TISSUE; MACACA FASCICULARIS; MACROPHAGES; RECEPTORS, CELL SURFACE;

EID: 34748827321     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e31812e6256     Document Type: Article

References (22)

1. Geijtenbeek TB, Torensma R, van Vliet SJ, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575-585.
2. Granelli-Piperno A, Pritsker A, Pack M, et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J Immunol. 2005;175:4265-4273.
3. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances transinfection of T cells. Cell. 2000;100:587-597.
4. Mahnke K, Guo M, Lee S, et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol. 2000;151:673-684.
5. Tacken PJ, de Vries IJ, Gijzen K, et al. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood. 2005;106:1278-1285.
6. Guo M, Gong S, Maric S, et al. A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Hum Immunol. 2000;61:729-738.
7. de Vries IJ, Lesterhuis WJ, Scharenborg NM, et al. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin Cancer Res. 2003;9:5091-5100.
8. Lu W, Arraes LC, Ferreira WT, et al. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med. 2004;10:1359-1365.
9. Bonifaz L, Bonnyay D, Mahnke K, et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med. 2002;196:1627-1638.
10. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769-779.
11. Mahnke K, Qian Y, Knop J, et al. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 2003;101:4862-4869.
12. Bonifaz LC, Bonnyay DP, Charalambous A, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med. 2004;199:815-824.
13. Park CG, Takahara K, Umemoto E, et al. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int Immunol. 2001;13:1283-1290.
14. Geijtenbeek TB, Koopman G, van Duijnhoven GC, et al. Rhesus macaque and chimpanzee DC-SIGN act as HIV/SIV gp120 transreceptors, similar to human DC-SIGN. Immunol Lett. 2001;79:101-107.
15. Schwartz AJ, Alvarez X, Lackner AA. Distribution and immunophenotype of DC-SIGN-expressing cells in SIV-infected and uninfected macaques. AIDS Res Hum Retroviruses. 2002;18:1021-1029.
16. Bashirova AA, Wu L, Cheng J, et al. Novel member of the CD209 (DC-SIGN) gene family in primates. J Virol. 2003;77:217-227.
17. Cosimi AB, Conti D, Delmonico FL, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol. 1990;144:4604-4612.
18. Engering A, van Vliet SJ, Hebeda K, et al. Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. Am J Pathol. 2004;164:1587-1595.
19. Santos PR, Michel-Salzat A, Butor C. Chimpanzee DC-SIGN alleles predict the existence of A and B isoforms, but do not support a role for resistance to HIV infection. AIDS Res Hum Retroviruses. 2005;21:820-829.
20. Brode S, Macary PA. Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology. 2004;112:345-351.
21. Pozzi LA, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol. 2005;175:2071-2081.
22. Kovacsovics-Bankowski M, Rock KL. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines. Eur J Immunol. 1994;24:2421-2428.